QRP Research SEMAX 10mg Nasal Spray
 
 
Semax is a synthetic heptapeptide derived from a short fragment of adrenocorticotropic hormone (ACTH) and has been investigated in experimental neuroscience, molecular neurobiology and neurotrophic signalling research.
Semax consists of the seven-amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Structurally, it combines the ACTH(4–7) sequence Met-Glu-His-Phe with a C-terminal Pro-Gly-Pro (PGP) tripeptide.
Unlike full-length ACTH, Semax has primarily attracted scientific interest for its neurobiological and regulatory signalling properties, rather than classical endocrine ACTH activity.
Experimental studies have investigated Semax in relation to neurotrophin expression, neuronal signalling, gene regulation and cellular responses to neurological stress. Particular research interest has focused on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), alongside their associated signalling pathways.
QRP Research SEMAX 10mg Nasal Spray is supplied as a pre-prepared research solution intended exclusively for controlled laboratory, analytical and scientific investigation.
Research Solution
The research solution contains:
Active Research Compound: Semax
Semax Content: 10mg
Peptide Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Solution: 0.9% Sodium Chloride (NaCl)
A 0.9% NaCl solution is used in the preparation of the finished research solution containing the active research compound.
Key Research Areas
Semax has been investigated experimentally in relation to:
BDNF and neurotrophic signalling
NGF-related pathways
Neuronal gene expression
Neurotransmitter-associated mechanisms
Neuronal plasticity research
Cellular stress-response pathways
Neuroinflammatory signalling
Neuronal survival mechanisms
ACTH-derived peptide biology
Pro-Gly-Pro (PGP) peptide signalling
Central nervous system research
Peptide signalling and regulatory mechanisms
A particularly interesting characteristic of Semax is its relationship to ACTH(4–7) combined with the C-terminal Pro-Gly-Pro sequence, creating a research peptide with characteristics distinct from full-length ACTH.
Its reported interactions with BDNF, NGF and associated neurotrophic pathways have made Semax a compound of interest for investigating molecular mechanisms involved in neuronal signalling and cellular adaptation.
Research findings involving Semax should not be interpreted as evidence of established cognitive-enhancing, neuroprotective, therapeutic or other clinical effects of this research product.
Product Specification
Compound: Semax
Research Name: ACTH(4–7)-Pro-Gly-Pro
Compound Type: Synthetic heptapeptide / ACTH-derived peptide
Amino Acid Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Peptide Length: 7 amino acids
Related Sequence: ACTH(4–7) + Pro-Gly-Pro
Form: Pre-prepared research solution / Nasal Spray
Active Compound: 10mg Semax
Solution: 0.9% Sodium Chloride (NaCl)
Brand: QRP Research
Application: Laboratory and scientific research
Why QRP Research?
QRP Research supplies specialist research materials with an emphasis on quality, consistency and traceability. Products are securely packaged and clearly identified for their intended laboratory application.
Storage
Store in accordance with appropriate laboratory procedures for prepared peptide research solutions. Protect from excessive heat, direct light and contamination.
Appropriate controlled storage procedures should be followed to preserve the stability and integrity of the research solution.
Research Use Notice
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research.
NOT for human consumption or administration.
NOT for animal consumption or administration.
NOT a medicine, food supplement or cosmetic product.
NOT intended to diagnose, treat, cure or prevent any disease.
No human dosing or administration instructions are provided.
Intended to be handled only by appropriately qualified researchers or laboratory professionals.
QRP Research SEMAX 10mg Nasal Spray is supplied strictly as a research material for non-clinical laboratory investigation.